VentriPoint Diagnostics Ltd. - ROE
VPTDF
Price:
$0.08499
Market Cap:
$22.52M
VentriPoint Diagnostics Ltd. (VPTDF) is a medical technology company dedicated to creating and bringing to market diagnostic tools for the global assessment of patients with cardiac conditions. The company's primary offering is the VentriPoint Medical System (VMS), an advanced medical imaging platform. This system, utilizing its VMS+ software, constructs precise three-dimensional representations of a patient's heart chambers by processing echocardiogram and magnetic resonance imaging (MRI) data. It is designed to yield consistent and accurate volumetric and functional measurements, including ejection fraction. Additionally, VentriPoint is actively developing a suite of specialized applicatio...[Read more]
Industry
Medical - Devices
IPO Date
2010-09-22
Stock Exchange
OTC
Ticker
VPTDF
PE Ratio
[-8.50]
ROE
[78.25%]
Current Ratio
[0.08]
Dividend Yield
[0%]
Enterprise Value
[25.07M]
Dividend History
The ROE as of June 2026 (TTM) for VentriPoint Diagnostics Ltd. (VPTDF) is 78.25%
According to VentriPoint Diagnostics Ltd.’s latest financial reports and current stock price. The company's current ROE is 78.25%. This represents a change of 291.39% compared to the average of 19.99% of the last 4 quarters.
VentriPoint Diagnostics Ltd. (VPTDF) Historical ROE (quarterly & annually)
How has VPTDF ROE performed in the past?
The mean historical ROE of VentriPoint Diagnostics Ltd. over the last ten years is -170.72%. The current 78.25% ROE has changed -145.84% with respect to the historical average. Over the past ten years (40 quarters), VPTDF's ROE was at its highest in in the March 2024 quarter at 128.88%. The ROE was at its lowest in in the December 2023 quarter at -652.12%.
Average
-170.72%
Median
97.71%
Minimum
-2568.15%
Maximum
227.72%
VentriPoint Diagnostics Ltd. (VPTDF) ROE by Quarter and Year
Discovering the peaks and valleys of VentriPoint Diagnostics Ltd. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 2.30%
Maximum Annual ROE = 227.72%
Minimum Annual Increase = -159.10%
Minimum Annual ROE = -2568.15%
| Year | ROE | Change |
|---|---|---|
| 2025 | 77.74% | -52.88% |
| 2024 | 164.98% | -106.42% |
| 2023 | -2568.15% | 2.30% |
| 2022 | -107.01% | 129.79% |
| 2021 | -46.57% | -159.10% |
| 2020 | 78.80% | -41.44% |
| 2019 | 134.55% | -37.16% |
| 2018 | 214.13% | -5.97% |
| 2017 | 227.72% | 95.26% |
| 2016 | 116.62% | -79.23% |
VentriPoint Diagnostics Ltd. (VPTDF) Average ROE
How has VPTDF ROE performed in the past?
The current ROE of VentriPoint Diagnostics Ltd. (VPTDF) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-775.14%
5-year avg
-495.80%
10-year avg
-170.72%
VentriPoint Diagnostics Ltd. (VPTDF) ROE vs. Peers
How is VPTDF’s ROE compared to its peers?
VentriPoint Diagnostics Ltd.’s ROE is less than Biotricity, Inc. (12.85%), less than ALR Technologies Inc. (51.64%), less than Zecotek Photonics Inc. (82.40%), less than Numinus Wellness Inc. (833.04%), greater than China Health Industries Holdings, Inc. (-1.00%), less than CelLBxHealth plc (0%), less than Sirona Biochem Corp. (221.45%), greater than Aurora Spine Corporation (-15.61%), greater than Vivesto AB (-23.13%), greater than Herbal Dispatch Inc. (-111.89%),
| Company | ROE | Market cap |
|---|---|---|
| 12.85% | $3.43M | |
| 51.64% | $9.75M | |
| 82.40% | $1.65K | |
| 833.04% | $6.41M | |
| -1.00% | $6.55K | |
| 0% | $21.98M | |
| 221.45% | $1.63M | |
| -15.61% | $12.34M | |
| -23.13% | $20.61K | |
| -111.89% | $11.67M |
Build a custom stock screener for VentriPoint Diagnostics Ltd. (VPTDF) and other stocks
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like VentriPoint Diagnostics Ltd. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
VentriPoint Diagnostics Ltd. (VPTDF) and other stocks custom spreadsheet templates
The easiest way to analyze a company like VentriPoint Diagnostics Ltd. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
Frequently asked questions❓
What is the ROE?
How can you use the ROE?
What is VentriPoint Diagnostics Ltd.'s ROE?
How is the ROE calculated for VentriPoint Diagnostics Ltd. (VPTDF)?
What is the highest ROE for VentriPoint Diagnostics Ltd. (VPTDF)?
What is the 3-year average ROE for VentriPoint Diagnostics Ltd. (VPTDF)?
What is the 5-year average ROE for VentriPoint Diagnostics Ltd. (VPTDF)?
How does the current ROE for VentriPoint Diagnostics Ltd. (VPTDF) compare to its historical average?